New disruptive one drop screening technology 300X more efficient than best-in-class automation
Culture and screen 100 million strain variants in just 3 days
BIOMILLENIA creates new routes for strain development and to build novel green chemistry products. Our disruptive development platform, based on licensed technology that was developed by Harvard University, the BROAD Institute and ESPCI Paris, uniquely combines single cell culture and advanced assay development with microfluidics-based ultrahigh-throughput screening. This unique technology platform delivers novel bacterial, fungal or yeast strain properties and enzymes for the manufacture of chemicals and natural products at throughputs and speeds several orders of magnitudes higher than with traditional methods. We “Unlock Nature’s Potential” for cost-competitive and sustainably manufactured novel biology-based products for a better life.